Page last updated: 2024-10-31

methoxyflurane and Glycogen Storage Disease

methoxyflurane has been researched along with Glycogen Storage Disease in 1 studies

Methoxyflurane: An inhalation anesthetic. Currently, methoxyflurane is rarely used for surgical, obstetric, or dental anesthesia. If so employed, it should be administered with NITROUS OXIDE to achieve a relatively light level of anesthesia, and a neuromuscular blocking agent given concurrently to obtain the desired degree of muscular relaxation. (From AMA Drug Evaluations Annual, 1994, p180)
methoxyflurane : An ether in which the two groups attached to the central oxygen atom are methyl and 2,2-dichloro-1,1-difluoroethyl.

Glycogen Storage Disease: A group of inherited metabolic disorders involving the enzymes responsible for the synthesis and degradation of glycogen. In some patients, prominent liver involvement is presented. In others, more generalized storage of glycogen occurs, sometimes with prominent cardiac involvement.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Krishna, G1
Paradise, RR1

Other Studies

1 other study available for methoxyflurane and Glycogen Storage Disease

ArticleYear
The effects of pyruvate on human atrial-muscle contractility depressed by methoxyflurane and by pentobarbital.
    Anesthesiology, 1972, Volume: 36, Issue:4

    Topics: Glycogen Storage Disease; Glycolysis; Heart; Heart Atria; Humans; Methoxyflurane; Muscle Contraction

1972